$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Indian version of capmatinib (capmatinib) price information and purchase channel safety
2026-02-01 22:25:32
Check Details
Detailed introduction to how long a box of Sotolaxib (AMG 510) can be taken
2026-02-01 22:25:32
Check Details
Advice on whether Krazati can be taken with food and when to take it
2026-02-01 22:25:32
Check Details
How long does it take for the side effects of Larotinib (Vitaika) to disappear on their own and how to deal with them?
2026-02-01 22:25:32
Check Details
Treatment plan and efficacy analysis of Selinisol (Silvio) combined with dexamethasone
2026-02-01 22:25:32
Check Details
What is the name of Vigabatrin (Okeda) and its trade name analysis?
2026-02-01 22:25:32
Check Details
Introduction to the onset time and observation results of treatment course of Mobosetinib (Anvili)
2026-02-01 22:25:32
Check Details
Tepotinib (Tuodekang) dose adjustment plan for special groups such as the elderly or those with liver and kidney insufficiency
2026-02-01 22:25:32
Check Details
Side effects, potential hazards and protective measures of Regorafenib (Belvango)
2026-02-01 22:25:32
Check Details
Top ten food taboos for Pazopanib (Vita) and precautions during use
2026-02-01 22:25:32
Check Details
How to deal with and remedial strategies after missing a dose of Opicapone
2026-02-01 22:25:32
Check Details
Scientific analysis of whether Fenelidone (Kesenda) is a kidney-protecting drug or a kidney-damaging drug
2026-02-01 22:25:32
Check Details
1
2
...
1999
2000
2001
2002
2003
2004
2005
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
2
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
3
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
4
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
5
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
6
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
7
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
8
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
9
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
10
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
11
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
12
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment